Juyi Li

Dr. Juyi Li


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in JAMA Cardiology
Verified
Journal Article
Open access
PDF file
JLJuyi Li
Juyi Li
XWXiufang Wang
Xiufang Wang
JCJian Chen
Jian Chen
HZhongmei Zhang
hongmei Zhang
DADeng Aiping
Deng Aiping
The epidemiology and clinical characterization of patients with coronavirus disease 2019 (COVID-19) has been reported.1-3 As angiotensin-converting enzyme (ACE) 2 serves as the receptor for severe acute respiratory syndrome coronavirus 2 to gain entry into cells,4 ACE2-expressing cells are susceptible to COVID-19 infection.5 The use of ACE inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) is common treatment in cardiovascular disorders, including hypertension, and data regarding the association of these drugs with ACE2 levels are conflicting.6,7 However, to our knowledge, there are no clinical data indicating whether patients with hypertension who are taking ACEIs/ARBs have increased severity of illness or risk of mortality during COVID-19 infection and whether these patients should continue to use ACEIs/ARBs or switch to other antihypertensive drugs.

18 May 2020 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Open access
PDF file
JLJuyi Li
Juyi Li
XWXiufang Wang
Xiufang Wang
JCJian Chen
Jian Chen
XZXiuran Zuo
Xiuran Zuo
HZHongmei Zhang
Hongmei Zhang
DADeng Aiping
Deng Aiping
The present study included 658 hospitalized patients with confirmed COVID‐19. Forty‐two (6.4%) out of 658 patients presented with ketosis on admission with no obvious fever or diarrhoea. They had a median (interquartile range [IQR]) age of 47.0 (38.0–70.3) years, and 16 (38.1%) were men. Patients with ketosis were younger (median age 47.0 vs. 58.0 years; P = 0.003) and had a greater prevalence of fatigue (31.0% vs. 10.6%; P < 0.001), diabetes (35.7% vs. 18.5%; P = 0.007) and digestive disorders (31.0% vs. 12.0%; P < 0.001). They had a longer median (IQR) length of hospital stay (19.0 [12.8–33.3] vs. 16.0 [10.0–24.0] days; P < 0.001) and a higher mortality rate (21.4% vs. 8.9%; P = 0.017). Three (20.0%) out of the 15 patients with diabetic ketosis developed acidosis, five patients (26.7%) with diabetic ketosis died, and one of these (25.0%) presented with acidosis. Two (7.4%) and four (14.3%) of the 27 non‐diabetic ketotic patients developed severe acidosis and died, respectively, and one (25.0%) of these presented with acidosis. This suggests that COVID‐19 infection caused ketosis or ketoacidosis, and induced diabetic ketoacidosis for those with diabetes. Ketosis increased the length of hospital stay and mortality. Meanwhile, diabetes increased the length of hospital stay for patients with ketosis but had no effect on their mortality.

26 May 2020 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
JLJuyi Li
Juyi Li
XWXiufang Wang
Xiufang Wang
JCJian Chen
Jian Chen
YCYi Cai
Yi Cai
DADeng Aiping
Deng Aiping
MYMing Yang
Ming Yang
In December, 2019, a cluster of acute respiratory illness caused by a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), occurred in Wuhan, China.1,2 Epidemiological, clinical characteristics, risk factors for mortality of patients infected with SARS‐CoV‐2, and risk factors in the susceptibility to SARS‐CoV‐2 included age and chronic disease have been reported.

3 June 2020 in Biomarkers in Medicine
Verified
Journal Article
Closed access
JLJuyi Li
Juyi Li
MLMeng Li
Meng Li
SZShasha Zheng
Shasha Zheng
MLMenglan Li
Menglan Li
MZMinghua Zhang
Minghua Zhang
HZhongmei Zhang
hongmei Zhang
Aim: We aimed to explore the biomarkers for disease progression or the risk of nonsurvivors. Materials & methods: This study included 134 hospitalized patients with confirmed COVID-19 infection. Th...

3 August 2022 in Frontiers in Endocrinology
Verified
Journal Article
Open access
JLJuyi Li
Juyi Li
XWXiufang Wang
Xiufang Wang
HMHuihui Mao
Huihui Mao
LWLi Wen
Li Wen
ADAiping Deng
Aiping Deng
CLChao Liu
Chao Liu
Maturity-onset diabetes of the young (MODY) is rare monogenic diabetes. However, MODY is often undiagnosed or misdiagnosed. In this study, we aimed to investigate the pathogenic gene for diabetes and provide precise treatment for diabetes patients in three families. Three families with suspected MODY were enrolled and screened for germline mutations using Whole exome sequencing (WES). Candidate pathogenic variants were validated in other family members and non-related healthy controls. Three heterozygous missense mutations in the ABCC8 gene (NM_001287174), c.1555 C>T (p.R519C), c.3706 A>G (p.I1236V), and c.2885 C>T (p.S962L) were found in families A, B, and C, respectively. All mutation sites cosegregated with diabetes, were predicted to be harmful by bioinformatics and were not found in non-related healthy controls. Two probands (onset ages, 8 and 12 years) were sensitive to glimepiride. However, an insufficient dose (2 mg/day) led to ketoacidosis. When the dosage of glimepiride was increased to 4 mg/day, blood sugar remained under control. A dose of 4 mg glimepiride daily also effectively controlled blood sugar in an adult patient 25-year-old. In addition, all patients were sensitive to liraglutide, which could control blood sugar better. These data suggest that ABCC8 was the pathogenic gene in three families with diabetes. Glimepiride (2 mg/day) was not effective in controlling blood sugar in children with ABCC8 mutations, however, 4 mg/daily glimepiride was effective in both adults and children. Moreover, liraglutide was effective in controlling blood sugar in both adults and children with ABCC8 mutations.

1 May 2023 in Journal of Geriatric Cardiology
Verified
Journal Article
Closed access
PDF file
WCWen-Zhuo Cheng
Wen-Zhuo Cheng
WWWei-Hua Wang
Wei-Hua Wang
ADAi-Ping Deng
Ai-Ping Deng
XDXiao Dang
Xiao Dang
CLChao Liu
Chao Liu
SJSi Jin
Si Jin
BACKGROUND Familial hypercholesterolemia (FH) is a common autosomal dominant hereditary disease. Its early diagnosis and intervention significantly improve the patient’s quality of life. However, there are few types of research on the FH pathogenic genes in China. METHODS In this study, we recruited a family diagnosed with FH and used whole exome sequencing (WES) to analyze the proband variants. Intracellular cholesterol level, reactive oxygen species (ROS) level, and the expression of pyroptosis-related genes were detected after overexpression of wild-type or variant LDLR in L02 cells. RESULTSA heterozygous missense variant predicted to be deleterious to LDLR (c.1879G > A, p.Ala627Thr) was identified in the proband. Mechanistically, intracellular cholesterol level, ROS level, and the expression of pyroptosis-related genes, nucleotide-binding oligomerization domain-like receptor family protein 3 (NLRP3) inflammasome and components (caspase 1, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) and NLRP3), gasdermin D (GSDMD), interleukin (IL) -18, IL-1β was elevated in the variant LDLR group, which was attenuated by inhibition of ROS. CONCLUSIONS FH is associated with a variant (c.1879G>A, p.Ala627Thr) in the LDLR gene. Regarding the mechanism, the ROS/NLRP3-mediated pyroptosis in hepatic cells may contribute to the pathogenesis of the LDLR variant.